These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 28589164)
21. Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? Zamvil SS; Slavin AJ Neurol Neuroimmunol Neuroinflamm; 2015 Feb; 2(1):e62. PubMed ID: 25635259 [TBL] [Abstract][Full Text] [Related]
22. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica. de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779 [TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin M antibodies to aquaporin-4 in neuromyelitis optica and related disorders. Jarius S; Franciotta D; Bergamaschi R; Wildemann B; Wandinger KP Clin Chem Lab Med; 2010 May; 48(5):659-63. PubMed ID: 20184532 [TBL] [Abstract][Full Text] [Related]
25. Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype. Pröbstel AK; Rudolf G; Dornmair K; Collongues N; Chanson JB; Sanderson NS; Lindberg RL; Kappos L; de Seze J; Derfuss T J Neuroinflammation; 2015 Mar; 12():46. PubMed ID: 25889963 [TBL] [Abstract][Full Text] [Related]
26. Accumulation of self-reactive naïve and memory B cell reveals sequential defects in B cell tolerance checkpoints in Sjögren's syndrome. Corsiero E; Sutcliffe N; Pitzalis C; Bombardieri M PLoS One; 2014; 9(12):e114575. PubMed ID: 25535746 [TBL] [Abstract][Full Text] [Related]
27. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder. Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159 [TBL] [Abstract][Full Text] [Related]
28. NMO spectrum disorders comprise the major portion of CNS inflammatory diseases in Thai patients: A cross sectional study. Apiwattanakul M; Kasemsuk C Mult Scler Relat Disord; 2014 Jan; 3(1):61-6. PubMed ID: 25877974 [TBL] [Abstract][Full Text] [Related]
29. A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis. Ramesh A; Schubert RD; Greenfield AL; Dandekar R; Loudermilk R; Sabatino JJ; Koelzer MT; Tran EB; Koshal K; Kim K; Pröbstel AK; Banerji D; ; Guo CY; Green AJ; Bove RM; DeRisi JL; Gelfand JM; Cree BAC; Zamvil SS; Baranzini SE; Hauser SL; Wilson MR Proc Natl Acad Sci U S A; 2020 Sep; 117(37):22932-22943. PubMed ID: 32859762 [TBL] [Abstract][Full Text] [Related]
30. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113 [TBL] [Abstract][Full Text] [Related]
31. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Mahmood Z; Muhammad K; Schmalzing M; Roll P; Dörner T; Tony HP Arthritis Res Ther; 2015 Mar; 17(1):61. PubMed ID: 25888920 [TBL] [Abstract][Full Text] [Related]
32. Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders. Fan X; Jiang Y; Han J; Liu J; Wei Y; Jiang X; Jin T Mediators Inflamm; 2016; 2016():3678152. PubMed ID: 27057097 [TBL] [Abstract][Full Text] [Related]
33. Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians. Majed M; Fryer JP; McKeon A; Lennon VA; Pittock SJ Neurol Neuroimmunol Neuroinflamm; 2016 Jun; 3(3):e231. PubMed ID: 27144221 [TBL] [Abstract][Full Text] [Related]
34. Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Kitley J; Woodhall M; Waters P; Leite MI; Devenney E; Craig J; Palace J; Vincent A Neurology; 2012 Sep; 79(12):1273-7. PubMed ID: 22914827 [TBL] [Abstract][Full Text] [Related]
35. Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid. Long Y; Chen M; Zhang B; Gao C; Zheng Y; Xie L; Gao Q; Yin J J Neuroimmunol; 2014 Apr; 269(1-2):62-7. PubMed ID: 24582827 [TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features in anterior visual pathway in neuromyelitis optica. Hokari M; Yokoseki A; Arakawa M; Saji E; Yanagawa K; Yanagimura F; Toyoshima Y; Okamoto K; Ueki S; Hatase T; Ohashi R; Fukuchi T; Akazawa K; Yamada M; Kakita A; Takahashi H; Nishizawa M; Kawachi I Ann Neurol; 2016 Apr; 79(4):605-24. PubMed ID: 26836302 [TBL] [Abstract][Full Text] [Related]
37. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands. van Pelt ED; Wong YY; Ketelslegers IA; Hamann D; Hintzen RQ Eur J Neurol; 2016 Mar; 23(3):580-7. PubMed ID: 26593750 [TBL] [Abstract][Full Text] [Related]
38. Neuromyelitis Optica (Devic's Syndrome): an Appraisal. Crout TM; Parks LP; Majithia V Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111 [TBL] [Abstract][Full Text] [Related]